Draft genome sequence of KPC-2-producing Pseudomonas aeruginosa recovered from a bloodstream infection sample in Brazil.
暂无分享,去创建一个
[1] V. Balcão,et al. Prospects for the Use of New Technologies to Combat Multidrug-Resistant Bacteria , 2019, Front. Pharmacol..
[2] K. Holt,et al. Small IncQ1 and Col-Like Plasmids Harboring blaKPC-2 and Non-Tn4401 Elements (NTEKPC-IId) in High-Risk Lineages of Klebsiella pneumoniae CG258 , 2019, Antimicrobial Agents and Chemotherapy.
[3] E. Pearlman,et al. Pseudomonas aeruginosa Effector ExoS Inhibits ROS Production in Human Neutrophils. , 2017, Cell host & microbe.
[4] M. Villegas,et al. The epidemiology of carbapenemases in Latin America and the Caribbean , 2017, Expert review of anti-infective therapy.
[5] A. Gales,et al. Emergence and spread of KPC-2-producing Pseudomonas aeruginosa isolates in a Brazilian teaching hospital. , 2015, Journal of global antimicrobial resistance.
[6] P. Nordmann,et al. Rapid Identification of Carbapenemase Types in Enterobacteriaceae and Pseudomonas spp. by Using a Biochemical Test , 2012, Antimicrobial Agents and Chemotherapy.
[7] Jessina C. McGregor,et al. Predictors of 30-Day Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: Impact of Delayed Appropriate Antibiotic Selection , 2007, Antimicrobial Agents and Chemotherapy.
[8] E. Tietze,et al. Comparative Biology of IncQ and IncQ-Like Plasmids , 2001, Microbiology and Molecular Biology Reviews.